Finally, our work provides a novel insight of epigenetic acetyltransferase KAT2A into the regulation of NLRP3 activation and IL‐1β production, which exhibits potential therapeutic approach for RA and relevant inflammatory diseases. The gene discussed is IL1B; the disease is rheumatoid arthritis.